RO7047650, Tecentriq 1 200 mg concentrate for solution for infusion
WO41994
Phase 3 small_molecule active
Quick answer
RO7047650, Tecentriq 1 200 mg concentrate for solution for infusion for Renal cell carcinoma (RCC) is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Renal cell carcinoma (RCC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active